A phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) in combination with axitinib in patients with metastatic renal cell carcinoma.
暂无分享,去创建一个
T. Choueiri | M. Michaelson | G. Sonpavde | E. Posadas | C. Theuer | D. McDermott | B. Seon | Meghara Walsh | K. Wall | M. Jivani | B. Adams